Multicenter Phase II Study of Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Multiforme
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 05 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Aug 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 28 Aug 2017 Planned primary completion date changed from 1 Aug 2018 to 1 Aug 2019.